Deutsche Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-106
| Closed | -$5K | – | 4272 |
|
|
2022
Q1 | $5K | Buy |
+106
| New | +$5.5K | ﹤0.01% | 4164 |
|
|
2020
Q2 | – | Sell |
-1,151
| Closed | -$36K | – | 4408 |
|
|
2020
Q1 | $36K | Buy |
1,151
+389
| +51% | +$13.3K | ﹤0.01% | 3695 |
|
|
2019
Q4 | $27K | Buy |
762
+212
| +39% | +$7.55K | ﹤0.01% | 4209 |
|
|
2019
Q3 | $18K | Sell |
550
-949
| -63% | -$34.5K | ﹤0.01% | 4362 |
|
|
2019
Q2 | $61K | Sell |
1,499
-653
| -30% | -$25.9K | ﹤0.01% | 4433 |
|
|
2019
Q1 | $86K | Sell |
2,152
-76
| -3% | -$3.04K | ﹤0.01% | 4360 |
|
|
2018
Q4 | $91K | Buy |
2,228
+287
| +15% | +$11.9K | ﹤0.01% | 4260 |
|
|
2018
Q3 | $81K | Sell |
1,941
-3,985
| -67% | -$153K | ﹤0.01% | 4569 |
|
|
2018
Q2 | $204K | Buy |
5,926
+3,637
| +159% | +$124K | ﹤0.01% | 4277 |
|
|
2018
Q1 | $76K | Sell |
2,289
-1,854
| -45% | -$63.7K | ﹤0.01% | 4615 |
|
|
2017
Q4 | $141K | Buy |
4,143
+1,561
| +60% | +$53.2K | ﹤0.01% | 4153 |
|
|
2017
Q3 | $87K | Sell |
2,582
-983
| -28% | -$31.6K | ﹤0.01% | 4207 |
|
|
2017
Q2 | $113K | Sell |
3,565
-32,659
| -90% | -$1.03M | ﹤0.01% | 4162 |
|
|
2017
Q1 | $1.18M | Buy |
36,224
+30,614
| +546% | +$965K | ﹤0.01% | 2545 |
|
|
2016
Q4 | $172K | Sell |
5,610
-2,564
| -31% | -$78.3K | ﹤0.01% | 3771 |
|
|
2016
Q3 | $262K | Sell |
8,174
-6,803
| -45% | -$227K | ﹤0.01% | 3514 |
|
|
2016
Q2 | $500K | Sell |
14,977
-87
| -0.6% | -$2.78K | ﹤0.01% | 3279 |
|
|
2016
Q1 | $422K | Buy |
15,064
+12,956
| +615% | +$370K | ﹤0.01% | 3315 |
|
|
2015
Q4 | $64K | Buy |
2,108
+527
| +33% | +$16.6K | ﹤0.01% | 4283 |
|
|
2015
Q3 | $47K | Sell |
1,581
-10,540
| -87% | -$338K | ﹤0.01% | 4486 |
|
|
2015
Q2 | $385K | Buy |
12,121
+5,165
| +74% | +$168K | ﹤0.01% | 3546 |
|
|
2015
Q1 | $228K | Buy |
6,956
+3,794
| +120% | +$121K | ﹤0.01% | 3720 |
|
|
2014
Q4 | $93K | Sell |
3,162
-2,460
| -44% | -$70.5K | ﹤0.01% | 4764 |
|
|
2014
Q3 | $157K | Buy |
5,622
+878
| +19% | +$24.6K | ﹤0.01% | 4226 |
|
|
2014
Q2 | $132K | Buy |
4,744
+3,376
| +247% | +$96.2K | ﹤0.01% | 4395 |
|
|
2014
Q1 | $2K | Sell |
1,368
-805
| -37% | -$24K | ﹤0.01% | 5358 |
|
|
2013
Q4 | $1K | Sell |
2,173
-12,583
| -85% | -$366K | ﹤0.01% | 5288 |
|
|
2013
Q3 | $67K | Sell |
14,756
-262,765
| -95% | -$7.15M | ﹤0.01% | 4567 |
|
|
2013
Q2 | $1.82M | Buy |
+277,521
| New | +$7.67M | ﹤0.01% | 2287 |
|
Other funds holding PFE
VCM
VPM
Deutsche Bank's PFE Position: Q1 2026 in Review
Deutsche Bank increased its Pfizer (PFE) stake by 1.7% in Q1 2026, buying an estimated $14.1M and bringing the position to 31,428,987 shares worth $883M. The position accounts for 0.29% of the portfolio, ranked #68.
Deutsche Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.22B in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Deutsche Bank held 31,428,987 shares of Pfizer worth $883M as of Q1 2026.
- Deutsche Bank bought 530,139 Pfizer shares in Q1 2026, an estimated $14.1M.
- Pfizer made up 0.29% of Deutsche Bank's portfolio in Q1 2026, its #68 holding.
- Deutsche Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Pfizer position peaked at $2.22B in Q3 2018.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.